Healthcare -
Biotechnology - NASDAQ - US
$ 1.065
-4.05 %
$ 123 M
Market Cap
-11.83
P/E
CHRS - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities CHRS - Coherus BioSciences, Inc.
145 M
LAST VALUE
74.50%
2 YEAR CAGR
162.13%
5 YEAR CAGR
81.59%
10 YEAR CAGR